Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Genitourinary Cancers
Would you offer pelvic nodal RT due to failure after previous pelvic node SBRT in oligorecurrent prostate cancer?
If so, are you worried about toxicity from overlap of treatments?
Related Questions
Does the presence of Atypical Intraductal Proliferation (AIP) on prostate needle biopsy influence your risk stratification?
If using 26-fraction moderate hypofractionation, what dose do you use for the intraprostatic dominant nodule SIB?
Do you advise Kegels/pelvic floor physical therapy to minimize urinary incontinence when irradiating the prostatic fossa?
Is there an SIB boost regimen for a dominant prostate lesion for 60 Gy/20 fx to the whole prostate?
Which patients do you consider to be good candidates for salvage local treatment after radiation therapy?
For patients undergoing bladder preservation therapy with TMT, how do you manage the urinary urgency and frequency during and after treatment?
In a patient with very high risk prostate cancer opting for prostatectomy, when, if ever, do you recommend neoadjuvant ADT?
Is there a benefit in proactively referring patients treated with pelvic radiation to see pelvic rehabilitation in the absence of any symptoms?
Would you offer salvage radiation for prostate bed recurrence on PSMA PET in a patient with limited bone mets?
Do you ever initiate on degarelix and then switch to leuprolide for patients with prostate cancer and cardiac risk factors receiving ADT?